What We're Reading: Page 272
Industry reads hand-picked by our editors
Mar 02, 2018
-
Harvard Business Review
Will personalized medicine mean higher costs for consumers?
-
Healthcare Dive
4 questions on Uber's new healthcare platform
-
The Washington Post
How proton therapy attacks cancer
-
CNBC
Activist Alex Denner to gain board control at Medicines Company
Mar 01, 2018
Feb 28, 2018
-
CNBC
Walgreens and AmerisourceBergen deal talks have cooled as takeover looks unlikely
-
Financial Times
Henri Termeer’s legacy is a vibrant biotech sector
-
Reuters
Why Oppenheimer Global fund is focusing on biotech as rates rise
-
Associated Press
Trump administration weighs mental health coverage option
Feb 27, 2018
-
MarketWatch
This could be the next $1 billion drug, if patients get on board
-
Chemical & Engineering News
Senti launches to improve cell therapies with synthetic gene circuits
-
Healthcare Dive
Apple to launch primary care clinics for employees, CNBC reports
Feb 26, 2018
-
CNBC
Buffett: Bezos, Dimon aim for something bigger on health than just shaving costs
-
The Wall Street Journal
Hidden profits in the prescription drug supply chain
-
The New York Times
Why your pharmacist can’t tell you that $20 prescription could cost only $8
-
MarketWatch
Expect better, more reliable flu tests
-
TechCrunch
What does it take to be a startup that raises huge sums quickly?
Feb 23, 2018
-
The Guardian
Hunt to crack down on NHS drug errors linked to up to 22,000 deaths
-
Medical Marketing & Media
Why Facebook's algorithm change may benefit patient influencers
-
The Sacramento Bee
'Hundreds of thousands of pills.' Opioid prescriptions send Granite Bay cardiologist to prison
Previous
